Factor V Inhibitor Evaluation, Plasma
Ordering Guidance
This test is for factor V inhibitors only. If the presence or type of inhibitor is unknown, first order APROL / Prolonged Clot Time Profile, Plasma, except for patients with known hemophilia A or B. When screening studies are needed for patients with known hemophilia A or B, order 8INHE / Factor VIII Inhibitor Evaluation, Plasma; or 9 INHE / Factor IX Inhibitor Evaluation, Plasma; respectively.
Shipping Instructions
Send all vials in the same shipping container.
Necessary Information
Specimen Required
Specimen Type: Platelet-poor plasma
Patient Preparation:
1. Patient must not be receiving Coumadin (warfarin) or heparin therapy
2. Fasting preferred
Collection Container/Tube: Light-blue top (3.2% sodium citrate)
Submission Container/Tube: Plastic vials
Specimen Volume: 3 mL in 3 plastic vials, each containing 1 mL
Collection Instructions:
1. Specimen must be collected prior to factor replacement therapy.
2. For complete instructions, see Coagulation Guidelines for Specimen Handling and Processing.
3. Centrifuge, transfer all plasma into a plastic vial, and centrifuge plasma again.
4. Aliquot plasma (1-2 mL per aliquot) into 3 separate plastic vials leaving 0.25 mL in the bottom of centrifuged vial.
5. Freeze plasma immediately (no longer than 4 hours after collection) at -20° C or, ideally, -40° C or below.
Additional Information:
1. Double-centrifuged specimen is critical for accurate results as platelet contamination may cause spurious results.
2. Each coagulation assay requested should have its own vial.
Profile Information
Test ID | Reporting Name | Available Separately | Always Performed |
---|---|---|---|
5INHT | FV Inhib Profile Tech Interp | No | Yes |
FACTV | Coag Factor V Assay, P | Yes | Yes |
Reflex Tests
Test ID | Reporting Name | Available Separately | Always Performed |
---|---|---|---|
5AINH | FV Inhib Profile Prof Interp | No | No |
5BETH | FV Bethesda Units, P | No | No |
F5_IS | Factor V Inhib Scrn | No | No |
Special Instructions
Specimen Type
Plasma Na CitSpecimen Minimum Volume
2 Plastic vials, each containing1 mL
Specimen Stability Information
Specimen Type | Temperature | Time | Special Container |
---|---|---|---|
Plasma Na Cit | Frozen | 14 days |
Reference Values
FACTOR V ACTIVITY ASSAY
>1 month: 70-165%
<1 month: Normal, full-term and premature newborn infants may have mildly decreased levels (≥30% to 35%) that reach adult levels within 21 days postnatal.
*See Pediatric Hemostasis References section in Coagulation Guidelines for Specimen Handling and Processing
FACTOR V INHIBITOR SCREEN:
Negative
GENERAL FACTOR BETHESDA UNITS:
≤0.5 Bethesda Units
Day(s) Performed
Monday through Friday
Report Available
1 to 3 daysSpecimen Retention Time
7 daysPerforming Laboratory
Mayo Clinic Laboratories in RochesterCPT Code Information
85390
85220
85335 (if appropriate)
85335 (if appropriate)
85390 (if appropriate)
LOINC Code Information
Test ID | Test Order Name | Order LOINC Value |
---|---|---|
5INHE | Factor V Inhib Profile, P | 96458-5 |
Result ID | Test Result Name | Result LOINC Value |
---|---|---|
5INHT | FV Inhib Profile Tech Interp | 69049-5 |
FACTV | Coag Factor V Assay, P | 3193-0 |
Forms
If not ordering electronically, complete, print, and send a Coagulation Test Request (T753) with the specimen.